BCL2 and non-small cell lung carcinoma: Furthermore, the BCL2 3′-UTR rs1564483 A allele was associated with a favorable survival outcome for male advanced NSCLC patients, and this effect was more obvious in patients with smoking, stage IIIA, and in patients without surgery but underwent chemotherapy or radiotherapy.